Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_assertion type Assertion NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_head.
- NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_assertion description "[Four specific DNA restriction endonuclease fragments (BamHI-DQ-beta 6.6, TaqI-DR-beta 4.3, TaqI-DR-beta 2.5 and TaqI-DR-beta 1.5 kb) are related to the susceptibility to Coxsackie B4 virus-associated type 1 diabetes while six specific DNA restriction endonuclease fragments (BamHI-DQ-alpha 12.5, -beta 3.7 and -beta 3.2 kb, TaqI-DQ-alpha 7.2, -beta 7.2 and -beta 5.4 kb) are related to the susceptibility to CMV-associated type 1 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_provenance.
- NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_assertion evidence source_evidence_literature NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_provenance.
- NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_assertion SIO_000772 2680367 NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_provenance.
- NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_assertion wasDerivedFrom befree-20150227 NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_provenance.
- NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_assertion wasGeneratedBy ECO_0000203 NP841606.RAFg0t5J6o45U2NN8YjgmP7ZLdUp1dTjXQ6F53d9aHKY0130_provenance.